
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for HWKN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for HWKN and 80,000+ other tickers.
See exactly how HWKN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HWKN and 80,000+ other tickers.
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade…

ROSEVILLE, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) announced today that it expects to release its financial results for its first quarter fiscal 2027 ended June 28, 2026 after the market closes on July 29, 2026 at approximately 4:10 p.m. Eastern Time.

Investors with an interest in Chemical - Specialty stocks have likely encountered both FUCHS SE - Unsponsored ADR (FUPBY) and Hawkins (HWKN). But which of these two stocks presents investors with the better value opportunity right now?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either FUCHS SE - Unsponsored ADR (FUPBY) or Hawkins (HWKN). But which of these two companies is the best option for those looking for undervalued stocks?

Hawkins is rated a 'sell' due to significant overvaluation versus historical averages and rising leverage from aggressive M&A. HWKN's growth-by-acquisition strategy, especially in water treatment, has driven revenue and EPS. Debt, leverage, and interest expense are rising; operating margins have declined to 10.4%, and interest coverage has dropped below 9x.

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.